Navigation Links
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States
Date:9/1/2009

SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc., today announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis(R), for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH). This increased strength formulation delivers the same dose of Ventavis in half the volume, which is expected to reduce inhalation time and further support patient compliance. The 20 mcg/mL formulation of Ventavis(R) is available immediately for pre-order, and fulfillment of initial prescriptions by specialty pharmacies is anticipated beginning the week of September 14.

"Ventavis(R) is the leading inhaled prostacylin therapy for patients with PAH, and this stronger formulation is a major advancement. Together with the easy-to-use, compact inhalation device called the I-neb AAD System, it will offer even more convenience to patients using Ventavis," said Kirk Taylor, M.D., Senior Vice President, U.S. Medical Group at Actelion Pharmaceuticals US.

"Ventavis(R) is the inhaled prostacyclin with the most extensive clinical experience, and is an extremely important treatment option for many patients with PAH. Shortening treatment times by 50% with the new 20 mcg/mL concentration will significantly benefit my patients," said Dr. Richard Channick, Professor of Medicine, Pulmonary and Critical Care Division, UC San Diego Medical Center and Editor-in-Chief, Advances in Pulmonary Hypertension.

About Ventavis(R)

Ventavis(R) is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) in patients with NYHA Class III or IV symptoms. In August 2009, the U.S. Food and Drug Adminsitration approved the new 20 mcg/ml formulation of Ventavis(R).

Ventavis(R) is an inhaled synthetic analog of prostacyclin (PGI2) that produces potent pulmona
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
2. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
3. GeneraMedix, Inc. Announces Sale of Innovative Epoprostenol Formulation to Actelion Ltd.
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... sciences product development company that identifies and advances ... various stages of development, today provided an update ... the merger of Cytopia Ltd. into YM, details ... The board of directors of Cytopia has unanimously ...
(Date:12/10/2009)... -- China Biologic,Products, Inc. (Nasdaq: CBPO ) ... plasma-based biopharmaceutical companies in China, today announced,that the ... bell at the,NASDAQ MarketSite in New York City ... , China Biologic,s common ... on,December 2, 2009, under the ticker symbol "CBPO." ...
(Date:12/10/2009)... -- Lotus Pharmaceuticals, Inc.,(OTC Bulletin Board: LTUS) ... and,producer of prescription drugs and licensed national ... of China ("PRC"), today reported that,effective December ... entity of Lotus,appointed Mr. Jinzhong HAN to ... division ("OTC Division"). , ...
(Date:12/10/2009)... that it has entered into a multi-year, sole-source supply agreement ... the use of Martek’s products in Fonterra’s infant formulas and ... , ... Columbia, MD (Vocus) December 10, ... today that it has entered into a multi-year, sole-source supply ...
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3
... fund to provide capital for local and regional innovations received ... Economic Development Corporations Board of Directors. , ,Developed as ... competition, the Family and Friends Innovation Development Fund will be ... A maximum of $7,500 per project for up to three ...
... in downtown Madison and you could try out the city's ... on Wednesday. , ,An initial coverage area of 10 ... is operational and available for testing. And until April 1, ... Internet service providers will be selling service for monthly rates. ...
... subsidiary of Milwaukee-based Merge Healthcare, said it will ... surgeons . , ,The company's OrthoWorks product will ... communications system (PACS), helping support joint arthroplasty, spine, ... the firm said. , ,Mayo Clinic has 70 ...
Other Biology Technology:Wireless advances in Madison, heats up in Waukesha 2
(Date:12/11/2009)... Western Reserve University has granted an 18-month, exclusive ... portfolio of insulin analogs. The company must reach ... to obtain an exclusive license on therapies designed ... Diabetes is developing treatments that it hopes will ... rapidly growing insulin market. Insulin is a therapeutic ...
(Date:12/11/2009)... in French . , Montreal, December ... molecular mechanism that prevents cancer. In the December 11 ... scientists from the Universit de Montral and the Universit ... molecule prevents the cancer-causing activity of cytokines, hormones that ... Crohns, in smokers and people exposed to asbestos. ...
(Date:12/11/2009)... the senior editor of the 4th edition of Springer,s ... was recently given the Victor A. McKusick Leadership Award. ... the field of human genetics, was presented to him ... of Human Genetics on 24 October 2009 in Honolulu, ... Genome Sciences at the University of Washington in Seattle. ...
Breaking Biology News(10 mins):Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Scientists identify natural anti-cancer defenses 2Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit 12600 1Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit 12600 2Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit 12600 3Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit 12600 4Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit 12600 5Medifast Inc to Expand Investment in Corporate Medifast Weight Control Centers 48751 1Medifast Inc to Expand Investment in Corporate Medifast Weight Control Centers 48751 2Medifast Inc to Expand Investment in Corporate Medifast Weight Control Centers 48751 3World Health Organization Declares A 28H1N1 29 Pandemic 48749 1World Health Organization Declares A 28H1N1 29 Pandemic 48749 2World Health Organization Declares A 28H1N1 29 Pandemic 48749 3
... have in common? They both feel the burn of ... in Africa while raising money for farmers and conservation. ... other groups, the Elephant Pepper Development Trust (EPDT) has ... a means of keeping elephants, buffalo, and other species ...
... the Virginia Commonwealth University Massey Cancer Center, in collaboration ... the crystal structure of a protein that plays a ... identification may help researchers gain a greater understanding of ... to co-opt nearby healthy cells into helping to feed ...
... Salk Institute for Biological Studies report that they have ... biology: the existence of a mechanism that insures that ... organs are arranged asymmetrically. , In research with zebra ... and his Salk Institute colleagues found that retinoic acid ...
Other Biology News:Key to elephant conservation is 'in the sauce' 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 2Vitamin A's paradoxical role in influencing symmetry during embryonic development revealed 3
Rotor for four tube-loaded buckets; ma RCF 2550g; sold without buckets...
... AccuSpot automates LC microfractionaction, spotting and preparation ... AccuSpot system, LC eluent can be accurately ... trace amounts (eg.50nl). Matrix solutions can be ... of target plated for MALDI-TOF-MS measurements. By ...
... Block MBS Start up kit. Includes configured ... choice of 2 MultiBlock satellite thermal ... blocks. User friendly software. Store/track ... height heated lid. Outstanding uniformity. ...
A camera based compact unit for high speed scanning of 2D barcoded tubes in a cluster rack. This reader has been designed to read both 96 and 48 tube rack configurations and be compatible with common...
Biology Products: